Tarsus Pharmaceuticals Inc
NASDAQ:TARS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Tarsus Pharmaceuticals Inc
NASDAQ:TARS
|
US |
|
F
|
Fluidigm Corp
F:FLB
|
US |
|
Boston Properties Inc
NYSE:BXP
|
US |
|
Camtek Ltd
NASDAQ:CAMT
|
IL |
|
L B Foster Co
NASDAQ:FSTR
|
US |
|
Gildan Activewear Inc
TSX:GIL
|
CA |
|
C
|
China Northern Rare Earth Group High-Tech Co Ltd
SSE:600111
|
CN |
|
Gurunavi Inc
TSE:2440
|
JP |
|
H
|
H & M Hennes & Mauritz AB
XMUN:HMSB
|
SE |
|
Westport Fuel Systems Inc
TSX:WPRT
|
CA |
|
Jhaveri Credits and Capital Ltd
BSE:531550
|
IN |
|
Taiga Motors Corp
TSX:TAIG
|
CA |
|
Bank Raya Indonesia Tbk PT
IDX:AGRO
|
ID |
|
J
|
John Menzies PLC
XBER:B3N
|
UK |
|
Resource Development Group Ltd
ASX:RDG
|
AU |
Profitability Summary
Tarsus Pharmaceuticals Inc's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
Profitability Score
We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
Profitability Score
Margins
Earnings Waterfall
Tarsus Pharmaceuticals Inc
Margins Comparison
Tarsus Pharmaceuticals Inc Competitors
| Country | Company | Market Cap |
Gross Margin |
Operating Margin |
Net Margin |
||
|---|---|---|---|---|---|---|---|
| US |
|
Tarsus Pharmaceuticals Inc
NASDAQ:TARS
|
2.8B USD |
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
865.7B USD |
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
576.1B USD |
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
295.4B USD |
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
218.1B GBP |
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
229.5B CHF |
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD |
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK |
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
155.1B USD |
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
119.6B USD |
Loading...
|
Loading...
|
Loading...
|
Return on Capital
Return on Capital Comparison
Tarsus Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | ROE | ROA | ROCE | ROIC | ||
|---|---|---|---|---|---|---|---|---|
| US |
|
Tarsus Pharmaceuticals Inc
NASDAQ:TARS
|
2.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
865.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
576.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
295.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
218.1B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
229.5B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
155.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
119.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
